News 30 Abr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 21 Mayo 2024 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...
News 17 Abr 2024 Symbio invests CHF 12 million in new research facility in Corminboeuf Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.
News 13 Mayo 2024 Canton of Zug funds institute for blockchain research The canton of Zug is contributing to the costs of setting up an institute for blockchain research. The project of the University of Lucerne and L...
News 11 Oct 2023 SFITS, the Swiss Foundation for Innovation and Training in Surgery In the intricate, ever-evolving realm of medical science, the Swiss Foundation for Innovation and Training in Surgery (SFITS) is the platform whe...
News 10 Mayo 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Aktuell 22 Ene 2024 DISCO Pharmaceuticals startet mit 20 Millionen Euro Kapital DISCO Pharmaceuticals ist mit einem Startkapital von 20 Millionen Euro neu auf dem Markt. Sein Team hat als erstes eine Methode entwickelt, die e...
News 07 Mayo 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
News 31 Oct 2023 Debiopharm invests CHF 30 million in Valais amidst workforce surge Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150...
News 12 Mar 2024 Nanoflex Robotics installs first robot for vascular interventions in the USA Nanoflex Robotics has installed its first remote-controlled robotics system for neurovascular procedures in the USA. The magnetically controlled ...
News 05 Mar 2024 Volaris Group agrees takeover of Zeit AG The Volaris Group, a software firm based in Canada, has announced that it has agreed a deal to acquire Zeit AG. Upon completion of the deal, the ...
Success stories 23 Abr 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
News 23 Abr 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
News 16 Abr 2024 OPEO has officially launched its first international subsidiary in Lausanne French industrial performance specialist OPEO has celebrated the launch of its first international subsidiary at EPFL’s SwissTech Convention Cent...
News 29 Feb 2024 Growth at Pistor leads to requirement for larger buildings As the first of a series of new construction projects, Pistor, a wholesaler and service provider in the gastronomy sector, has built and opened a...
Actualités 30 Abr 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
Aktuell 21 Mayo 2024 InSphero spannt mit Genome Biologics zusammen Das Biotech-Unternehmen InSphero hat mit Genome Biologics eine Vereinbarung zur Vermarktung der 3D Cardiac Organoid Platform unterzeichnet. Die P...
Exemples de Réussite 02 Mayo 2024 Comment BeiGene favorise l’accès au traitement du cancer à l’échelle mondiale Depuis son siège européen à Bâle, en Suisse, BeiGene collabore de manière stratégique avec des parties prenantes dans le monde entier pour f...